Horizon Discovery to Provide Access to Novel Base Editing Technology

Gene editing

Home » Emerging technologies » Gene editing

Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics

Expands strategic partnerships with AnGes and Takeda Accelerates novel OMNI gene editing platform into a broad therapeutic product pipeline January 15, 2020 06:00 AM Eastern Standard Time NEW YORK–(BUSINESS...

Synthego Adopts Good Manufacturing Practices for Highest-Quality Genome Engineering for Clinical Applications

LogicBio Therapeutics Announces Collaboration with Takeda to Develop New Genome Editing Candidate LB-301 for the Treatment of Crigler-Najjar Syndrome

– LB-301 is a recombinant AAV vector with a UGT1A1 gene leveraging GeneRide™ genome editing platform for the treatment of Crigler-Najjar syndrome – – The collaboration agreement grants Takeda an exclusive option to...

Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

SNIPR BIOME Strengthens Lead in CRISPR-based Medicines to Treat Microbiomes

CRISPR Prime

With CRISPR Prime, gene therapies are one step closer to curing millions

Mammoth Biosciences Strengthens Executive Management With Biotech Veterans, Peter Nell and Ted Tisch

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery

Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

Cyrus Biotechnology and the Broad Institute of MIT and Harvard Launch Multi-Target Collaboration to Develop Optimized CRISPR Gene Editing Technology

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Inscripta

Video: Leveraging the power of digital genome engineering – Inscripta Workshop at SynBioBeta 2019

eGenesis Announces $100 Million Series B Financing

Inscripta

Video: Genome-scale mapping of genotype – Inscripta Workshop at SynBioBeta 2019

CRISPR

Fast-forward 10 years from now. What does the CRISPR genome editing field look like to you?